These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3146142)

  • 1. Plasminogen activators in the intestine of patients with inflammatory bowel disease.
    de Bruin PA; Crama-Bohbouth G; Verspaget HW; Verheijen JH; Dooijewaard G; Weterman IT; Lamers CB
    Thromb Haemost; 1988 Oct; 60(2):262-6. PubMed ID: 3146142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix.
    Grøndahl-Hansen J; Kirkeby LT; Ralfkiaer E; Kristensen P; Lund LR; Danø K
    Am J Pathol; 1989 Oct; 135(4):631-6. PubMed ID: 2508479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease but not chronic ulcerative colitis induces the expression of PAI-1 in enteric neurons.
    Laerum OD; Illemann M; Skarstein A; Helgeland L; Ovrebø K; Danø K; Nielsen BS
    Am J Gastroenterol; 2008 Sep; 103(9):2350-8. PubMed ID: 18844621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.
    de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Lamers CB
    Cancer Res; 1987 Sep; 47(17):4654-7. PubMed ID: 3621160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activators in human nasal polyps and mucosa.
    Larsen K; de Maat MP; Jespersen J
    Rhinology; 1997 Dec; 35(4):175-7. PubMed ID: 9532638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDAVP induces systemic release of urokinase-type plasminogen activator.
    Levi M; ten Cate JW; Dooijewaard G; Sturk A; Brommer EJ; Agnelli G
    Thromb Haemost; 1989 Sep; 62(2):686-9. PubMed ID: 2510348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impaired fibrinolytic response to the venous occlusion test in patients with cryptogenic colitis].
    Gris JC; Schved JF; Raffanel C; Dubois A; Ribard D; Balmes JL
    Gastroenterol Clin Biol; 1991; 15(12):933-8. PubMed ID: 1783249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator profiles in neoplastic tissues of the human colon.
    de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Dooijewaard G; van den Ingh HF; Lamers CB
    Cancer Res; 1988 Aug; 48(16):4520-4. PubMed ID: 3260815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.
    Ganesh S; Sier CF; Griffioen G; Vloedgraven HJ; de Boer A; Welvaart K; van de Velde CJ; van Krieken JH; Verheijen JH; Lamers CB
    Cancer Res; 1994 Aug; 54(15):4065-71. PubMed ID: 8033138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.
    Grøndahl-Hansen J; Agerlin N; Munkholm-Larsen P; Bach F; Nielsen LS; Dombernowsky P; Danø K
    J Lab Clin Med; 1988 Jan; 111(1):42-51. PubMed ID: 3121772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
    Hayashi K; Nakashima Y; Sueishi K; Tanaka K
    Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma.
    Häckel C; Czerniak B; Ayala AG; Radig K; Roessner A
    Cancer; 1997 Jan; 79(1):53-8. PubMed ID: 8988726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
    De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S
    Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.
    Kim SJ; Shiba E; Kobayashi T; Yayoi E; Furukawa J; Takatsuka Y; Shin E; Koyama H; Inaji H; Takai S
    Clin Cancer Res; 1998 Jan; 4(1):177-82. PubMed ID: 9516968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
    Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.
    Hasui Y; Suzumiya J; Marutsuka K; Sumiyoshi A; Hashida S; Ishikawa E
    Cancer Res; 1989 Feb; 49(4):1067-70. PubMed ID: 2492205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
    Skelly MM; Troy A; Duffy MJ; Mulcahy HE; Duggan C; Connell TG; O'Donoghue DP; Sheahan K
    Clin Cancer Res; 1997 Oct; 3(10):1837-40. PubMed ID: 9815571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.